Hangzhou Tigermed Consulting Co., Ltd（stock symbol: 300347） is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality.
Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, 63 offices across China and 12 overseas offices in Hong Kong China, Taiwan China, USA, Switzerland, Canada, Korea, Australia, Japan, Malaysia, Singapore, India and Romania with over 3600 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1060 clinical trials. Tigermed is recognized as “The Innovative Clinical CRO” in China，owning to our involvement of over 150 innovative drugs.
For more information about Tigermed, please visit http://www.tigermed.net
63offices in China mainland
12 overseas offices - Hong Kong China, Taiwan China, Korea, Japan, Malaysia, Singapore, India, Australia, Canada, USA, Switzerland, Romania